GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bluemtec Co Ltd (XKRX:439580) » Definitions » Net Income From Continuing Operations

Bluemtec Co (XKRX:439580) Net Income From Continuing Operations : ₩-4,568 Mil (TTM As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Bluemtec Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Bluemtec Co's net income from continuing operations for the three months ended in Mar. 2025 was ₩-1,609 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-4,568 Mil.

Bluemtec Co Net Income From Continuing Operations Historical Data

The historical data trend for Bluemtec Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bluemtec Co Net Income From Continuing Operations Chart

Bluemtec Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Net Income From Continuing Operations
-641.17 -7,678.75 -14,330.66 -2,342.13 -4,801.46

Bluemtec Co Quarterly Data
Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,842.51 2,421.94 -3,438.06 -1,942.83 -1,609.28

Bluemtec Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-4,568 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bluemtec Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bluemtec Co Ltd (XKRX:439580) » Definitions » Net Income From Continuing Operations
Comparable Companies
XKRX:471820 HKSE:06618 WBA HKSE:00241 TSE:3088 JSE:CLS TSE:3349 SHSE:603939 BSP:RADL3 SAU:4164 TSE:3391 TSE:7649 TSE:9989 TSE:3141 MEX:FRAGUAB TSE:3549 SHSE:603883 SAU:4163 JSE:DCP SZSE:002727
Traded in Other Exchanges
N/A
Address
45 Dream Industrial Complex 1-ro, Cheongbuk-eup, Gyeonggi-do, Pyeongtaek-si, KOR
Website
https://www.bluemtec.com
Bluemtec Co Ltd is a company whose main business is selling prescription drugs through an e-commerce platform. It operates two pharmaceutical distribution platforms, BluePharmKorea targeting hospitals and clinics, and KoolPharm targeting pharmacies and provide IT services to operate and advance these two platforms. In addition, it is operating BlueLabs, which provides services and website development for pharmaceutical companies and medical institutions.

Bluemtec Co Headlines

No Headlines